Alkem enters into licensing agreement with BioTherapeutics
Under the licensing agreement, Alkem will carry out the clinical development of “SON-080” in India with support from Sonnet and enable global and India regulatory filings
Under the licensing agreement, Alkem will carry out the clinical development of “SON-080” in India with support from Sonnet and enable global and India regulatory filings
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
The company disclosed that several employees of a subsidiary had their business email addresses stolen
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
The company has received Form 483 with three observations
The countrywide initiative aims to spread awareness, educate the public & ensure that no one is left behind in the fight against respiratory diseases
The initiative will focus on advocating for cleaner air
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
Subscribe To Our Newsletter & Stay Updated